Efficacy of alteplase thrombolysis for ED treatment of pulmonary embolism with shock

American Journal of Emergency Medicine

Volumn 21, Issue 5, 2003, Pages 438-440

  Le Conte, Philippe ^a   Huchet, Ludovic ^b   Trewick, David ^b   Longo, Céline ^b   Vial, Irshaad ^b   Batard, Eric ^b   Yatim, Danielle ^b   Touzé, Marie Dominique ^b   Baron, Denis ^b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Alteplase; Pulmonary embolism; Shock; Thrombolysis

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD PRESSURE; BOLUS INJECTION; CLINICAL ARTICLE; EMERGENCY WARD; FEMALE; FIBRINOLYTIC THERAPY; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; LUNG EMBOLISM; MALE; MORTALITY; PRIORITY JOURNAL; SHOCK; TREATMENT OUTCOME;

EID: 0141870109     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(03)00098-6     Document Type: Article

References (22)

1. Konstantinides S, Geibel A, Olsschewski M, et al: Association between thrombolytic treatment and the prognosis of hemoynamically stable patients with pulmonary embolism. Results of a multicenter registry. Circulation 1997;96:882-888
2. Jerjes-Sanchez C, Ramirez-Rivera A, De Lourdes et al: Streptokinase versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis 1995;2:227-229
3. Goldhaber SZ: Thrombolysis in pulmonary embolism: a debatable indication. Thromb Haemost 2001;86:444-451
4. Sors R, Pacouret G, Azarian R, et al: Hemodynamic effects of bolus vs 2h infusion of Alteplase in acute pulmonary embolism. A randomized controlled trial. Chest 1994;106:712-717
5. Goldhaber S, Agnelli G, Levine M: Reduced dose bolus Alteplase vs conventional Alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. Chest 1994;106:718-724
6. Task Force Report: guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000;21:1301-1336
7. Wicki J, Perneger TV, Junod AF, et al: Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med 2001;161:92-97
8. Wolfe TR, Hartsell SC: Pulmonary embolism: making sense of the diagnostic evaluation. Ann Emerg Med 2001;37:504-514
9. Kasper W, Konstantinides S, Geibel A, et al: Management strategies and determinants of outcome in acute massive pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997;30:1165-1171
10. Stein PD, Henry JW: Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995;108:978-981
11. The PIOPED Investigators: Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990;263:2753-2759
12. Mercat A, Diehl JL, Meyer G, et al: Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 1999;27:461-463
13. Jardin F, Genevray B, Brun-Ney D, et al: Dobutamine: a hemodynamic evaluation in pulmonary embolism shock. Crit Care Med 1985;13:1009-1012
14. The Urokinase Pulmonary Embolism Trial: A national cooperative study. Circulation 1973;96:882-888
15. Dalla-Volta S, Palla A, Santolicandro A, et al: PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen Activator Italian Multicenter Study 2. J Am Coll Cardiol 1992;20:520-526
16. Goldhaber SZ, Haire WD, Fedstein ML, et al: Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right ventricular function and pulmonary perfusion. Lancet 1993;341:507-511
17. Konstantinides S, Geibel A, Heusel G, et al: Management strategies and prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus Alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002;347:1143-1150
18. Goldhaber SZ, Feldstein ML, Sors H: Two trials of reduced bolus Alteplase in the treatment of pulmonary embolism. An overview. Chest 1994;3:725-726
19. Goldhaber SZ, Visani L, De Rosa M: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-1389
20. Meyer G, Gisselbrecht M, Diehl JL, et al: Incidence and predictors of major hemorrhagic complications from thrombolytic therapy in patients with massive pulmonary embolism. Am J Med 1998;105:472-477
21. Kanter DS, Mikkola KM, Patel SR, et al: Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest 1997;111:1241-1245
22. Courtney DM, Kline JA: Identification of prearrest clinical factors associated with outpatient fatal pulmonary embolism. Acad Emerg Med 2001;8:1136-1142